User profiles for Patrick Gordon

Patrick Gordon

king's college
Verified email at nhs.net
Cited by 5087

[PDF][PDF] 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory …

…, I Garcia‐De La Torre, P Gordon… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate new classification criteria for adult and juvenile idiopathic
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …

Risk factors for clinical endometritis in postpartum dairy cattle

TJ Potter, J Guitian, J Fishwick, PJ Gordon, IM Sheldon - Theriogenology, 2010 - Elsevier
Bacterial contamination of the uterine lumen after parturition occurs in most dairy cattle. The
presence of clinical endometritis beyond three weeks post partum depends on the balance …

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis …

…, I García‐De la Torre, P Gordon… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM).
Methods Expert surveys, logistic regression, and conjoint analysis were used to develop …

The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire

AS Patel, RJ Siegert, K Brignall, P Gordon, S Steer… - Thorax, 2012 - thorax.bmj.com
Rationale Health status is impaired in patients with interstitial lung disease (ILD). There is a
paucity of tools that assess health status in ILD. The objective of this study was to develop …

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

PA Gordon, JB Winer, JE Hoogendijk… - Cochrane Database …, 2012 - cochranelibrary.com
Background Idiopathic inflammatory myopathies are chronic diseases with significant
mortality and morbidity. Whilst immunosuppressive and immunomodulatory therapies are …

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs

…, K Irving, R Gorodkin, M Aris, J Burke, P Gordon… - …, 2017 - academic.oup.com
Patrick Gordon , Patrick Gordon … Jo Ledingham, Nicola Gullick, Katherine Irving, Rachel
Gorodkin, Melissa Aris, Jean Burke, Patrick Gordon, Dimitrios Christidis, Sarah Galloway, Eranga …

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies

…, L Chung, D Fiorentino, MD George, P Gordon… - …, 2021 - academic.oup.com
Objectives To identify clinical factors associated with cancer risk in the idiopathic inflammatory
myopathies (IIMs) and to systematically review the existing evidence related to cancer …

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

…, BM Feldman, I García-De La Torre, P Gordon… - RMD open, 2017 - rmdopen.bmj.com
Objective To describe the methodology used to develop new classification criteria for adult
and juvenile idiopathic inflammatory myopathies (IIMs) and their major subgroups. Methods …

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

…, K Bechman, V Cuthbert, J Galloway, P Gordon… - …, 2022 - academic.oup.com
Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

Rituximab in the treatment of inflammatory myopathies: a review

S Fasano, P Gordon, R Hajji, E Loyo… - Rheumatology, 2017 - academic.oup.com
Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with
myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in refractory …